HIV medications stop the virus from making copies ... to some people without HIV as part of a preexposure prophylaxis (PrEP) regimen. Cytochrome P4503A, or CYP3A, is an enzyme in the liver that ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

When breakthrough infections have been reported, they have typically occurred when people on PrEP have been exposed to HIV that has resistance to the drugs in PrEP. PrEP is an extremely effective way ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

People who inject drugs are eligible for PrEP in many countries. For example, in the United States, the Centers for Disease Control and Prevention recommends PrEP if you have an injection partner ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...